Microbot Medical  logo
Microbot Medical MBOT
$ 0.9 -2.6%

Квартальный отчет 2024-Q3
добавлен 13.11.2024

report update icon

Microbot Medical Мультипликаторы 2011-2024 | MBOT

Мультипликаторы по годам Microbot Medical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.1 -1.3 -3.5 -6621.7 -5.3 -3.3 -4.5 -7.2 -0.9 -2.1 -2.4 -1.7 -0.7

P/S

- - - - - - - - 286.9 69.4 52.3 35.4 12.1

EPS

-1.1 -1.8 -1.6 -1.3 -1.7 -2.4 -2.8 0.4 0.0 -0.2 -0.6 -1.0 -1.5

EV (Enterprise Value)

13.1 млн 16.6 млн 28.1 млн 41.1 млн 15 млн 23.7 млн 24.6 млн 68.3 млн 54.6 млн 96 млн 89.2 млн 56.1 млн 15.9 млн

EBITDA per Share

-0.96 -1.82 -1.59 -0.00128 -1.69 -2.48 -2.41 -10.1 -595 -778 -1.03 тыс. -1.19 тыс. -2.96 тыс.

EV/EBITDA

-2.2 -6669.0 -1.3 -2.6 -4.5 -6.9 -0.9 -2.0 -1.7 -1.9 -0.1

PEG

-0.0 -0.0 -0.0 -66.27 -0.18 -0.31 -0.08 -0.07 -0.03 -0.16 -0.06 -0.05 -0.03

P/B

2.6 2.3 2.7 2497.7 1.2 18.3 3.4 40.9 -100.3 12.0 4.2 3.5 1.4

P/CF

-1.4 -1.5 -4.2 -8268.3 -5.7 -4.4 -7.0 -85.5 -1.1 -2.5 -2.2 -2.4 -0.7

ROE %

-238.61 -180.66 -78.67 -37.72 -22.98 -547.66 -76.16 -569.75 10895.85 -557.70 -176.81 -203.73 -198.87

ROA %

-128.98 -138.07 -67.47 -34.89 -19.52 -118.88 -68.87 -286.91 -171.61 -100.97 -63.62 -94.43 -84.62

ROCE %

-218.95 -182.21 -78.97 -36.77 -22.41 -544.66 -50.20 -372.73 -318.97 -147.69 -88.03 -88.50 -138.78

Current Ratio

2.2 4.2 7.0 18.8 7.4 1.2 20.7 4.2 1.5 2.3 3.5 4.7 3.1

DSO

- - - - - - - - 166.8 149.8 180.5 83.0 80.1

DIO

- - - - - - - - - - - - -

DPO

- - 52.9 - - - - - - - 304.2 300.8 1812.2

Операционный цикл

- - - - - - - - - - 180.5 83.0 80.1

Финансовый цикл

- - -52.9 - - - - - - - -123.7 -217.8 -1732.0

Все данные представлены в валюте USD

Мультипликаторы поквартально Microbot Medical

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.2 -0.17 -0.17 - -0.21 -0.25 -0.36 - -0.49 -0.49 -0.45 - -0.36 -0.35 -0.34 - -0.35 -0.26 -0.31 - -0.44 -0.36 -0.48 - -0.6 -0.66 -0.5 - -0.45 -0.09 0.04 - -0.08 -0.01 -0.01 -0.08 -0.005 -1.07 -1.62 -0.15 -0.04 -0.21 -0.14 -0.13 -0.17 -0.15 -0.17 -0.07 -0.54 0.03 -0.45 - -0.31 -0.29 -0.42

EBITDA per Share

- - -0.17 - - - -0.36 - -0.48 -0.5 -0.44 - -0.35 -0.34 -0.33 - -0.33 -0.26 -0.3 - -0.41 -0.35 -0.47 - -0.58 -0.65 -0.54 - -0.52 -0.04 -0.05 - -0.05 0.01 0.06 - 0.11 -1.1 -1.51 - -0.08 -0.13 -0.12 - -0.14 -0.14 -0.16 - -0.14 -0.19 -0.22 - -0.37 -0.47 -0.32

ROE %

-196.83 -145.64 -129.09 -116.25 -178.93 -208.36 -225.34 -131.26 -145.55 -97.17 -68.52 -37.47 -47.64 -43.51 -38.66 -26.87 -32.81 -28.59 -25.84 -17.05 -149.23 -275.47 -412.98 -386.02 -462.18 -406.16 -339.92 -165.45 -735.20 -1228.79 -1722.37 -1709.26 -1698.08 -1117.16 1984.45 5340.88 5293.92 5235.78 2497.56 -383.13 -2241.38 -2242.51 -2075.39 -1988.50 -149.97 -218.70 -173.50 -203.73 -224.42 -148.01 -191.59 -131.62 -40.41 -37.62 -53.59

ROA %

-154.59 -120.38 -108.24 -94.49 -141.30 -160.59 -172.90 -103.44 -116.41 -82.57 -60.73 -34.33 -43.74 -40.18 -35.75 -24.86 -29.90 -25.54 -22.64 -14.48 -43.35 -67.17 -94.12 -84.30 -153.17 -193.17 -230.93 -149.59 -436.50 -654.54 -872.58 -860.72 -860.89 -574.16 -327.14 -84.12 -92.62 -100.95 -98.43 -69.36 -86.12 -94.92 -71.68 -63.62 -56.01 -92.85 -75.97 -94.43 -102.49 -65.54 -84.31 -56.01 -17.20 -16.01 -22.80

ROCE %

- - - - -62.79 -125.57 -167.30 -131.84 -146.12 -97.61 -68.20 -37.30 -47.24 -42.89 -38.33 -26.58 -32.26 -28.01 -25.15 -16.65 -148.46 -274.58 -411.94 -387.97 -400.36 -280.95 -151.36 -37.43 -75.47 -101.10 -81.48 -14.27 -5.38 41.53 2809.05 5464.43 5355.76 5238.21 2328.15 -360.79 -405.30 -341.15 -247.17 -127.96 -164.26 -156.06 -152.71 -112.64 -170.11 -191.27 -219.12 -193.59 -57.46 -66.11 -70.02

Current Ratio

3.7 5.4 6.1 2.2 5.8 7.7 4.6 4.2 4.0 5.3 6.6 7.0 10.8 12.5 13.1 13.3 13.3 13.3 13.3 6.7 6.7 6.7 6.7 1.3 1.3 1.3 1.3 19.8 19.8 19.8 19.8 2.9 2.9 2.9 2.9 1.3 1.0 1.0 1.0 0.0 1.2 1.2 1.2 1.6 1.6 1.6 1.6 1.9 1.9 1.9 1.9 1.7 1.7 1.7 1.7

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 4.1 6.6 30.1 383.8 16.5 176.6 632.7 519.0 220.7 30.6 35.2 35.1 47.6 38.1 40.4 11.7 - 22.2 21.2 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 4.1 6.6 30.1 383.8 16.5 176.6 632.7 519.0 220.7 30.6 35.2 35.1 47.6 38.1 40.4 11.7 - 22.2 21.2 -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 4.1 6.6 30.1 383.8 16.5 176.6 632.7 519.0 220.7 30.6 35.2 35.1 47.6 38.1 40.4 11.7 - 22.2 21.2 -

Все данные представлены в валюте USD